all these rights and warrants complicate the

New Post Public Reply Private Reply Replies (0) Message Board
microcaps
690
all these rights and warrants complicate the picture
presumably many exercised their right to purchase rights on last couple days of eligibility-May 30-31 and then sold some of the ensuing shares into the market-but not below 3 pps bc they want to make money off the warrants exercisable at pps of 3 dollars june 29-so they want pps to remain above 3 dollars

intermix that unpredictability w the guessing games re whether they will actually have producible oil-with the company tight roping a fine line re what they've said-what does their cryptic language mean??-I dont know- and holding info re tests so far

my guess is no big field or we would know already-they tend to get excited re discoveries- and they are searching for smaller fields reachable via the drill hole



Zion Oil & Gas Announces Subscription Rights Offering
Rights offering to prepare Zion Oil & Gas for future exploration and production in Israel

DALLAS and CAESAREA, Israel, April 4, 2018 /PRNewswire/ -- Zion Oil & Gas, Inc. (NASDAQ: ZN) today announced it will be offering rights (the "Rights Offering" to holders of its common stock of record at the close of business on April 13, 2018. Pursuant to the Rights Offering, each holder of shares of common stock on the record date of April 13, 2018 will receive non-transferable rights to subscribe for Rights, with each Right comprised of one (1) share of our Common Stock, par value $0.01 per share (the "Common Stock" and one (1) Common Stock Purchase Warrant to purchase an additional one (1) share of Common Stock. Each Right may be purchased at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of our Common Stock at a warrant exercise price of $3.00. The warrants will become exercisable on June 29, 2018 and will continue to be exercisable for one (1) year thereafter. The warrants are not tradeable.

https://mma.prnewswire.com/media/662752/Zion_...raphic.jpg

The Company filed an amendment to the prospectus supplement dated April 2, 2018 to reflect the new record date of April 13, 2018. Accordingly, all references to the "Record Date" or similar term in the original prospectus supplement indicating a Record Date of March 12, 2018 should be replaced with the new Record Date of April 13, 2018. The Rights Offering is scheduled to expire on May 31, 2018.

The Rights Offering is being made pursuant to Zion's effective shelf registration statement on Form S-3 (File Registration Number 333-216191) on file with the Securities and Exchange Commission ("SEC" and the related prospectus supplement filed with the SEC on April 2, 2018, as amended by Amendment No. 1 thereto filed on April 3, 2018.

This communication does not constitute an offer to sell, or the solicitation of an offer to buy, any securities, and there will be no sale of any securities in any state in which such an offer, solicitation, or purchase would be unlawful prior to the registration or qualification of such securities under the securities laws of any such state.

NOTICE: Zion Oil & Gas, Inc. has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should carefully read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about Zion Oil & Gas and its offering. The Subscription Rights Offering is made only by means of the Prospectus Supplement dated April 2, 2018 of the Prospectus dated March 7, 2017, as subsequently amended, filed with the SEC, and related documents. A copy of the prospectus may be obtained, free of charge, on the SEC website at www.sec.gov, or by contacting us at rightsoffering@zionoil.com or by calling at 888-891-9466.

Zion Oil & Gas, Inc. (ZNOG) Stock Research Links

ZNOG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading